Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Babady

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Journal of Clinical Microbiology|May 18, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences|May 13, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Emerging Infectious Diseases|February 21, 2018
Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in TestingMini Kamboj, Jennifer Brite, Anoshe Aslam, et al.
Nature Medicine|June 26, 2020
Determinants of COVID-19 disease severity in patients with cancerElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Determinants of Severity in Cancer Patients with COVID-19 IllnessElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.
Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of Clinical Microbiology|May 18, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
Medrxiv : the Preprint Server for Health Sciences|May 13, 2022
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1Kyle G Rodino, David R Peaper, Brendan J Kelly, et al.
The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Emerging Infectious Diseases|February 21, 2018
Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in TestingMini Kamboj, Jennifer Brite, Anoshe Aslam, et al.
Nature Medicine|June 26, 2020
Determinants of COVID-19 disease severity in patients with cancerElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Determinants of Severity in Cancer Patients with COVID-19 IllnessElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.
Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 15